PROSTAGLANDIN DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT

PROSTAGLANDIN DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT

PROBLEM TO BE SOLVED: To provide a preventive and/or therapeutic agent for bone loss diseases (primary osteoporosis, secondary osteoporosis, carcinoses bone metastasis, hypercalcemia, Paget's disease, bone deletion, bone disorders of osteonecrosis, osteogenesis after operation of a bone and bon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANBE TORU, YOSHIDA HIDEYUKI, NISHIURA AKIO, ABE NOBUTAKA, MARUYAMA TORU, KOBAYASHI KAORU, MARUYAMA TAKAYUKI
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a preventive and/or therapeutic agent for bone loss diseases (primary osteoporosis, secondary osteoporosis, carcinoses bone metastasis, hypercalcemia, Paget's disease, bone deletion, bone disorders of osteonecrosis, osteogenesis after operation of a bone and bone grafting alternative) and the like. SOLUTION: A specific new prostaglandin derivative, its nontoxic salt or its cyclodextrin clathrate is very useful as an active ingredient of the preventive and/or therapeutic agent. COPYRIGHT: (C)2010,JPO&INPIT